TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH NEBULIZED BETA 2-AGONIST OR COMBINED NEBULIZED BETA 2-AGONIST AND ANTICHOLINERGIC ADMINISTRATION

• 1. 作为β2肾上腺素受体促效剂的5-(2-{6-(2,2-二氟-2-苯基乙氧基)己基氨基}-1-羟乙基)-8-羟基喹啉-2(1H)-酮的甲磺酸盐 [P] . 中国专利： CN102264703B . 2014.07.30
• 2. 作为β2肾上腺素受体促效剂的5-(2-{6-(2,2-二氟-2-苯基乙氧基)己基胺基}-1-羟乙基)-8-羟基喹啉-2(1H)-酮的甲磺酸盐 [P] . 中国专利： CN102264703A . 2011-11-30
• 3. Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration [P] . AU2016202597B2 . 2018-01-18

  机译： 雾化的β2-激动剂或雾化的β2-激动剂与抗胆碱能药物联合治疗慢性阻塞性肺疾病

• 4. Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration [P] . NZ712403A . 2017-04-28

  机译： 雾化的β2-激动剂或雾化的β2-激动剂与抗胆碱能药物联合治疗慢性阻塞性肺疾病

• 5. TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH NEBULIZED BETA 2-AGONIST OR COMBINED NEBULIZED BETA 2-AGONIST AND ANTICHOLINERGIC ADMINISTRATION [P] . 美国专利： US2017202787A1 . 2017-07-20

  机译： 贝塔2-促效剂或贝塔2-促效剂联合抗炎药治疗慢性阻塞性肺疾病

• 1. Systematic review and meta-analysis of additional Yupingfeng powder combined with western medicine treatment at stable period of chronic obstructive pulmonary disease [J] . Yun-Ru Chen, Si-Dan Long, Dao-Wen Yang, 海南医科大学学报(英文版) . 2020,第023期
• 2. Systematic review and meta-analysis of additional Yupingfeng powder combined with western medicine treatment at stable period of chronic obstructive pulmonary disease [J] . Yun-Ru Chen, Si-Dan Long, Dao-Wen Yang, 海南医科大学学报（英文版） . 2020,第023期
• 3. Effects of terbutaline combined with methylprednisolone on pulmonary function, blood gas analysis and inflammatory factors in patients with chronic obstructive pulmonary disease [J] . Jin-Jin Cheng, Hong-Rong Guo, Bo Huang, 海南医科大学学报（英文版） . 2017,第024期
• 4. Comparison of Disease Related Health Care Resource Utilization (HRU) and Costs in Chronic Obstructive Pulmonary Disease (COPD) Patients Receiving Nebulized Long-Acting β2-Agonists (LABAs) [J] . Yaozhu Chen, Charles Maken, Vamsi Bollu Chest . 2014,第4期
• 5. Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized β2-Agonists [J] . Vamsi Bollu, Annie Guérin, Geneviève Gauthier, Drugs - Real World Outcomes . 2017,第1期
• 6. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease. [J] . Cyr MC, Beauchesne MF, Lemiere C, The annals of pharmacotherapy . 2010,第4期
• 7. CHRONIOUS: An open, ubiquitous and adaptive chronic disease management platform for Chronic Obstructive Pulmonary Disease (COPD), Chronic Kidney Disease (CKD) and renal insufficiency [C] . Rosso R., Munaro G., Salvetti O., 32nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2010
• 8. Targeted delivery of anti-inflammatory and anti-oxidant drugs for treatment of chronic obstructive pulmonary disease. [D] . Xiang, Yun. 2014
• 9. Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized β2-Agonists [O] . Vamsi Bollu, Annie Guérin, Geneviève Gauthier, 2017
• 10. Effects of combined therapy with nebulized β₂-agonist and anticholinergics in severe exacerbation of chronic obstructive pulmonary disease. A randomized controlled trial [O] . S. N. Avdeev, G. S. Nuralieva, S. Z. Batyn, 2007

• 1. The influence of β2AR polymorphisms as a predictor of successful short acting β2-agonist nebulization during asthmatic exacerbation [J] . Nasir M ,Nor Hidayah AB ,Rashidi A . 海南医学院学报 . 2010,第007期
• 2. A Report on Treatment of Chronic Obstructive Pulmonary Disease with Electroacupuncture Combined with Traditional Chinese Medicine [J] . Zuyao Xie ,Gaiqin Yang . 临床护理研究 . 2021,第004期
• 3. 磷-氮系膨胀型阻燃剂1，2-二（2-氧代-5，5-二甲基-1，3-二氧-2-磷杂环己基-2-氨基）乙烷及其同系物的合成 [C] . 高富业 ,欧育湘 ,陈宇 . 中国兵工学会阻燃学会98'信息与学术年会 . 1998
• 4. 有机介质中1-（2-甲氧基-3-甲基-4-氯-苯基）-2-丙醇的酶促不对称转酯化反应及其动力学研究 [A] . 季峥 . 2007